市場調查報告書

心臟結構設備市場 - 成長,趨勢,預測

Structural Heart Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921267
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
心臟結構設備市場 - 成長,趨勢,預測 Structural Heart Devices Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 114 Pages
簡介

主要結構的心臟病,有關聯的適應症,以及心房中膈缺損症,主動脈閥狹窄症,末梢動靜脈瘺等。作為剖腹手術的替代手段,微創設備的採用踏實增加,使心臟結構設備市場需求擴大。還有,醫療保健費的改善,從風險企業合作夥伴資金提供推動創新的醫療設備企業,小規模商務的創新調查對創新計劃的踏實參加,也提高心臟血管設備的需求。

本報告提供心臟結構設備的世界市場調查,市場概要,各類型、治療、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 心臟瓣膜設備
    • 封堵器、輸送系統
    • 環狀成形術環
    • 其他
  • 各治療
    • 替換
    • 修複式
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Biomerics, LLC
    • Boston Scientific Corporation
    • Braile Biomedica
    • Comed BV
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • Lepu Medical
    • LivaNova PLC
    • Medtronic PLC

第7章 市場機會及未來趨勢

目錄
Product Code: 67126

In the modern advances of medical sciences, many medical heart device companies and institutes are focusing upon several ways to replace or repair structural heart diseases such as congenital and age-related heart defects.

There is a significant growth over the decade in the type of complexities which are presented by the cardiovascular patients. To curb them, structural heart devices play a significant role in the treatment of chronic heart disorders. The initiatives and awareness programs by the government and private sector in collaboration with cardiac specialized hospitals also drive the adoption of such devices in the healthcare facilities.

Some of the major structural heart diseases having a significant burden across the world include atrial septal defects, aortic stenosis, peripheral arteriovenous fistula, along with related indications. As an alternative to open surgeries, there has been a steady increase in the adoption of minimally invasive devices which also drives the demand for structural heart devices market, over the forecast period.

Key Market Trends

Replacement Procedures is Expected to Contribute to Significant Revenue Over the Forecast Period

The transcatheter aortic valve replacement (TAVR) is one of the noticeable advances under the replacement procedures segment, TAVR has gained attention because of growing adoption of minimally invasive surgical procedures. Under sedative medications, the procedure lasts for a shorter period than open heart surgery and is highly useful for patients with severe aortic stenosis (AS). In many multispeciality healthcare facilities, the replacement therapies are considered to be safer, offer better effectiveness and are applicable to a greater range of patient population, as per the study published in the Annals of Cardiothoracic Surgery, 2017.

Furthermore, the better participation by the government authorities to push more on innovation and better distribution network across the cities are expected to drive and provide steady growth to replacement procedures, over the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America is the major contributing geography for the structural heart devices market. The presence of better awareness in the society regarding the heart indications and well-organized infrastructure in the cities of the United States ad Canada, along with the faster approval process of medical devices in the region, are a few of the important factors driving the growth of the studied market in this region.

The better healthcare expenditure, boost to innovative medical device companies through funding from venture partners, and steady participation of small business innovation research in the innovative projects drives the demand of cardiovascular devices and positively impacting the growth of structural heart devices.

Competitive Landscape

The market is moderatley fragmented with signicant contribution of several public and private private companies operating at the global level. Many companies are now exploring collabroation opportunities in many of medical tourism destinations across the emerging markets of the world. Some of the top players include Abbott Laboratories, Boston Scientific Coporation, Medtronic PLC, Lepu Medical, Edwards Life Sciences Corporation, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Technological Advancement in Medical Devices
    • 4.2.3 Growing Participation of Government and Private Sector
  • 4.3 Market Restraints
    • 4.3.1 Less Accessibility to New Technology in the Emerging Markets
    • 4.3.2 Irregular Reimbursement Scenario
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Heart Valve Devices
    • 5.1.2 Occluders & Delivery Systems
    • 5.1.3 Annuloplasty Rings
    • 5.1.4 Other Products
  • 5.2 By Procedure
    • 5.2.1 Replacement Procedures
    • 5.2.2 Repair Procedures
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 France
      • 5.3.2.2 Germany
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biomerics, LLC
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Braile Biomedica
    • 6.1.5 Comed B.V.
    • 6.1.6 Edwards Lifesciences Corporation
    • 6.1.7 JenaValve Technology, Inc.
    • 6.1.8 Lepu Medical
    • 6.1.9 LivaNova PLC
    • 6.1.10 Medtronic PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS